Search for Anti-Aging information and Medical News in Genetic Engineering within the Longevity and Age Management section
Resarchers used CRISPR/Cas9 gene editing to eliminate mutant huntington protein aggregates in the brains of mice.Continue reading…
Using CRISPR gene editing to remove a specific protein, researchers were able to slow the growth of cells that characterize many types of cancer.Continue reading…
Chinese Scientists are about to be the first in the world to use the gene-editing technique on humans, in the hopes of treating cancer.Continue reading…
Week of July 13, 2009
William H. Andrews, PhD
Dr. Andrews leads the scientific research and development function of Sierra Sciences. His team is now pursuing direct molecular approaches to temporarily activate telomerase expression, and is performing highâ€throughput screening and drug discovery efforts.
While Director of Molecular Biology at Geron Corporation, he was one of the principal discoverers of the telomerase genes. He was awarded 2nd place as "National Inventor of the Year" in 1997 for this work, with his name appearing on numerous related patents and publications. He earned his Ph.D. in Molecular and Population Genetics at the University of Georgia. He has more than 25 refereed publications and abstracts.
At the upcoming Anti-Aging Conference: Clinical Applications for In-Office Procedures in San Jose, California (September 9-12, 2009), Dr. Andrews will present, Telomerase Activation: The Future of Antiâ€Aging Medicine, on Friday, September 11th.
For more information call the A4M today; 1-888-997-0112.Continue reading…
To view the video, click here.
Dr. Greekos will be speaking at the upcoming A4M World Stem Cell Clinical Summit to be held in conjunction with the Anti-Aging Conference: Clinical Appliations for In-Office Procedures in San Jose, California, September 9-12, 2009. His presentation, Clinical Applications of Stem cells in Orthopedic Practices will explore the current uses of peripheral blood as well as bone marrow aspirate for patients with degenerative arthritic conditions with emphasis on joints. For more information, call 1-888-997-0112. Continue reading…
Week of June 15, 2009
Dipnarine Maharaj, MD
Dr. Dipnarine Maharaj is the Medical Director and founder of the South Florida Bone Marrow/Stem Cell Transplant Institute, one of the few completely outpatient bone marrow/stem cell transplant facilities in the country. He was also involved in the establishment of bone marrow/ stem cell transplant programs at the University of Miami and for other communities in Florida. He has been involved with clinical research studies using stem cells in the areas of cardiac regeneration, neurodegenerative diseases, and cancer treatments. Most recently, he has secured an Investigator-initiated IND from the FDA to study a novel treatment of solid tumors using only healthy white blood cells. His innovative approach to medicine has earned him international recognition.
At the upcoming A4M WORLD STEM CELL CLINICAL SUMMIT, to be held in conjunction with theAnti-Aging Conference: Clinical Applications for In-Office Procedures in San Jose, California (September 9-12, 2009), Dr. Maharaj will present, Stem Cells and Bone Marrow Transplants: Current Medical Applications and Clinical Studies in Regenerative Medicine, on Saturday, September 12th.
For more information, call 1-888-997-0112.
Zannos G. Grekos, MD speaks about Ischemic Cardiomyopathy Patients and Stem Cell Therapy at the 16th Annual Congress on Anti-Aging and Regenerative Medicine in Las Vegas, Nevada. Preview his discussion of the use of stem cells for regeneration of tissues and organs, repair of defective cell types and delivery of genetic therapies and chemo-therapeutic agents into the desired tissue. To view the video preview, click here.
Dr. Grekos will present "Stem Cells: Basic Concepts Current Clinical Applications and Case Studies" at the upcoming Anti-Aging Conference: Clinical Applications for In-Office Procedures in San Jose, California, September 9-12 2009. For more information, call 1-888-997-0112.
Xuetao Pei, PhD
Cell Biologist and Biophysicist
Dr. Pei is Professor and Director of Beijing Institute of Transfusion Medicine and SCRM Research Center, Chief Scientist of Key Project of State High-tech Project “Stem Cell and Tissue Engineering”. His main research fields are stem cell biology, stem cell therapy and regenerative medicine.
At the upcoming Anti-Aging Conference: Clinical Applications for In-Office Procedures in San Jose, California (September 9-12, 2009), Dr. Pei will present, Stem Cell Research and Liver Regeneration, on Friday, September 11th.
This lecture will focus on the research currently underway on bone marrow and embryonic stem cell derived heptatocytes and their interaction with the microenvironment. Also discuss will be the microfabrication tools this research group has devised to improve cellular therapies in liver disease. For more information, call 1-888-997-0112. Continue reading…